本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kura Oncology, Inc

10.40
-0.2050-1.93%
盘后:10.30-0.0950-0.91%19:30 EDT
成交量:121.29万
成交额:1,263.77万
市值:9.23亿
市盈率:-3.09
高:10.68
开:10.60
低:10.31
收:10.60
52周最高:13.90
52周最低:7.36
股本:8,877.44万
流通股本:7,060.22万
量比:0.89
换手率:1.72%
股息:- -
股息率:- -
每股收益(TTM):-3.3668
每股收益(LYR):-3.1784
净资产收益率:-167.71%
总资产收益率:-31.30%
市净率:19.05
市盈率(LYR):-3.27

数据加载中...

2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report
2023/06/12

重要事件披露

Form 8-K - Current report
2023/06/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/02

重要事件披露

Form 8-K - Current report
2023/05/10

重要事件披露

Form 8-K - Current report
2023/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/19

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/13

重要事件披露

8-K - Current report